SS Innovations Announces Chief Financial Officer Transition

Company Overview - SS Innovations International, Inc. is focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [4] - The company offers products such as the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures including robotic cardiac surgery [4] Leadership Transition - Arvind Palaniappan has been appointed as the Interim Chief Financial Officer effective May 1, 2025, as part of a planned leadership transition [1] - Anup Sethi, the departing CFO, will remain available to advise the company during the transition period [1][2] - The company has initiated a search for a permanent successor for the CFO role [1] Executive Commentary - Dr. Sudhir Srivastava, Chairman and CEO, expressed confidence in Arvind Palaniappan's capabilities, highlighting his extensive experience in accounting and financial management [2] - Dr. Srivastava acknowledged Anup Sethi's contributions over the past seven years, particularly in building strong accounting and finance functions that supported the launch of over 80 surgical robotic systems [2] Profile of Interim CFO - Arvind Palaniappan is a Chartered Accountant with over 30 years of experience in accounting, financial management, risk consulting, and compliance [3] - He has served in various executive roles, including Managing Director at Accenture Solutions in India, and has been the principal of Trogon Consulting since February 2020 [3] Product Features - The SSi Mantra Surgical Robotic System features a modular design with 3 to 5 robotic arms, an ergonomic surgeon command center, and advanced imaging capabilities [5] - It has been clinically validated in India for over 100 different types of surgical procedures [5]